semaglutide compounding fda enforcement news FDA Warns on Certain Forms of Compounded Semaglutide

In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking

29.47

★★★★☆4.8 (126)

New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect

28.87

★★★★★4.9 (98)

The push to make weight-loss drugs more affordable is running into legal limits. Telehealth company Hims & Hers pulled a less expensive oral version of Wegovy after lawsuits from Novo Nordisk and

28.63

★★★★★5.0 (157)

Compounded "semaglutide" is not FDA-approved

20.96

★★★★★4.7 (84)

The FDA has sent 30 warning letters to telehealth companies for falsely marketing compounded GLP-1s, which are not FDA-approved and can pose risks to patients. FULL STORY:🔗https://tinyurl.com/3ztf9uj2

26.36

★★★★★4.9 (203)

Report: FDA must enforce rules on compounded GLP-1s

22.73

★★★★★5.0 (176)

Compound versions of GLP-1 drugs for weight loss halted by FDA

28.69

★★★★★4.8 (132)